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Abstract 
 
Background: Neonatal sepsis refers to the presence of bacteria in the blood of a new-born 
baby. Differing estimates of disease burden have been reported from high-income countries 
compared with reports from low-income and middle-income countries (LMICs), where the 
highest burden of diseases has been reported. This study has analysed the different 
estimates to understand the extent of the burden of neonatal sepsis in LMICs. 
Method: A systematic review and meta-analysis study method was used. The reviewed 
studies were accessed through an electronic web-based search strategy. From selected 
studies, 52 studies met the inclusion criteria. 
Results: The average epidemiology of neonatal sepsis in the developed countries is 
1.21/1000 (95% CI: 8.39– -5.97) live births compared to the value of 18/1000 (95% CI: 25.18– -
10.82) in LMICs. Among the LMICs Liberia resulted in the highest value of 68/1000 (95% CI: 
75.18 – 60.82) live births. Bacterial etiological agents, Klebsiella pneumoniae (40%), 
Escherichia coli (14%), Staphylococcus aureus (13%) accounted for the number of neonatal 
sepsis respectively. The results identified that the rate of Late-Onset was higher than that of 
the Early-Onset Sepsis. Both Sub-Saharan Africa and Southern Asian countries have an 
average neonatal mortality risk of 30/1000 live births, and Nigeria has the highest risk of 
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36/1000 live births. 
 
Conclusion: 
The four different estimates of the prevalence of neonatal sepsis; average epidemiology, 
etiological agents, rate of EOS vs LOS, and the neonatal mortality risk were found to be high 
in LMICs. Despite LMICs have established possible prevention and treatment strategies, 
neonatal sepsis remains a major healthcare challenge in LMICs. 
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